Mental Health and Neuro

Ketamine, Spravato, TMS, psychedelic therapy, neurofeedback, stellate ganglion block

Cash-pay mental health has grown rapidly as treatment-resistant depression, PTSD, and concierge psychiatry have driven patients away from insurance-based mental healthcare. Ketamine infusion is now offered in over 1,000 US clinics, with treatment series at $2,400 to $4,800. TMS therapy is sometimes insurance-covered but increasingly paid in cash for faster access. Spravato (FDA-approved esketamine nasal spray) sits in an in-between category, sometimes covered with prior authorization.